Vol. 19 No. 2 (2009): Psychiatry and Clinical Psychopharmacology

Published: 2021-03-01

Reviews

Physiological approach to neuropsychiatric diseases; role of autonomic nervous system and melatonin

Ahmet Korkmaz, M. Alpay Ateş, Ayhan Algül, Cengiz Başoğlu

(173-182)

Full Text PDF Abstract

New Horizons in the treatment of schizophrenia: Palliperidone

K. Oğuz Karamustafalıoğlu

(S341-S342)

Full Text PDF Abstract

Functioning in schizophrenia and paliperidone: a review of studies with personal and social performance scale

Ömer Aydemir

(S335-S340)

Full Text PDF Abstract

A new perspective to safety and tolerability of antispychotic drugs

Ali Saffet Gönül, Çağdaş Eker, Fatma Şimşek

(S326-S334)

Full Text PDF Abstract

A novel technology in treatment with antipsychotic drugs; paliperidone

Nesrin Dilbaz, Aslı Enez Darçın

(S316-S325)

Full Text PDF Abstract

Unmet needs in the treatment of schizophrenia: Psychopharmacological dimensions

K. Oğuz Karamustafalıoğlu

(S311-S315)

Full Text PDF Abstract

Probable cognitive and neurobiological mechanisms of religious and mystic experiences

Ertuğrul Eşel

(193-205)

Full Text PDF Abstract

Is placebo efficacious? Ethica

Ceren Göker, Ayşegül Yılmaz, Hakan Kumbasar

(183-192)

Full Text PDF Abstract

Meta-analysis and its place in evidence based medicine

Cengizhan Açıkel

(164-172)

Full Text PDF Abstract

Original Papers

Bireysel ve sosyal performans ölçe¤i’nin Türkçe sürümünün geçerlilik ve güvenilirlik çal›flmas›

Ömer Aydemir, Alp Üçok, Ayşen Esen Danacı, Tarık Canpolat, Gülşah Karadayı, Birgül Emiroğlu, Fatih Sarıöz

(93-100)

Full Text PDF Abstract

The effects of pharmachotherapy on serum folic acid and vitamin B12 levels in patients with schizophrenia, bipolar disorder and major depressive disorder

Saliha Özsoy, Hasan Basri İzgi, Ertuğrul Eşel, Tayfun Turan, Mustafa Baştürk, Seher Sofuoğlu

(128-134)

Full Text PDF Abstract

The levels of depression and somatization in restless legs syndrome

Deniz Tuncel, Fatma Özlem Orhan, M. Fatih Karaaslan

(143-147)

Full Text PDF Abstract

Adjuvant folate with escitalopram treatment and homocystein, folate, vitamin B-12 levels in patients with major depressive disorder

Cengiz Başoğlu, M. Alpay Ateş, Ayhan Algül, Osman Metin İpluçioğlu, Ömer Geçici, Onur Yılmaz, Ü. Başar Semiz, Servet Ebrinç, Murat Gülsün, Ömer Özcan, Selim Kılıç, Mesut Çetin

(135-142)

Full Text PDF Abstract

Long-acting typical and atypical antipsychotics in treatment of schizophrenia: A retrospective comparison

Osman Virit, Abdurrahman Altindag, Feridun Bulbul, Haluk Asuman Savas, Alican Dalkilic

(119-127)

Full Text PDF Abstract

Effects of selective serotonin reuptake inhibitors on auditory brainstem responses in patients with depressive disorder

Ömer Geçici, Abdullah Ayçiçek, Ömer Özbulut, Kürşat Duman, Fethullah Kenar, Sefa Dereköy

(113-118)

Full Text PDF Abstract

Ziprasidone versus risperidone: Comparison of clinical efficacy and cardiac, extrapyramidal, and metabolic side effects in patients with acute exacerbation of schizophrenia and schizoaffective disorders

Bülent Sönmez, Erdal Vardar, Gülay Durmuş Altun, Ercan Abay, Deniz Bedel

(101-112)

Full Text PDF Abstract

Case Report

Galactorrhea due to fluoxetine in a patient with depression and a pituitary adenoma: A case report

A. Betül Okat Girayalp

(159-163)

Full Text PDF Abstract

Clozapine induced obsessions treated with sertraline in an adolescent with schizophrenia

Murat Coskun, Salih Zoroglu

(155-158)

Full Text PDF Abstract

The effect of quetiapine on alcohol/drug dependents and its abuse: A case series and literature review

Cüneyt Evren, Hasan Turan Karatepe, Agah Aydın, Ercan Dalbudak, Duran Cakmak

(148-154)

Full Text PDF Abstract

Letter to the Editor

Dikkat Eksikliği- Hiperaktivite Bozukluğu’nun Tedavi Maliyetini Öngörmek İçin Öncü Bir Klavuz Önerisi

A. Evren Tufan

(208-210)

Full Text PDF Abstract

Serum Lityum Seviyesi Çok Yüksek Olan Hastaların Prognozu Kötü Olmayabilir

Nedim Havle, Cem İlnem, Ferhan Yener, Cengiz Dayan

(206-207)

Full Text PDF Abstract

EDITORIAL

In perspective of meta-analyses: Are all of the antidepressants similar?

Mesut Çetin, Cengizhan Açıkel

(87-92)

Full Text PDF Abstract